DepYMed

Topspin finds an inspirational Remedy in NYC

A Long Island-born investment fund with a taste for tech has acquired an award-winning Manhattan-based digital health platform. Topspin Partners, formerly headquartered in Roslyn Heights and now based in Mamaroneck, announced Wednesday that it has taken a controlling interest in Remedy Health Media, a New York City digital specialist known for its inspirational videos and award-winning online brands. Financial terms of the deal were not disclosed. In addition to its popular HealthCentral website, a respected…


Innovations, advice abound in SBU’s 2017 Boot Camp

By GREGORY ZELLER // These boots are made for talking – and now, several enterprising innovators have a firmer grasp on what to say, and how to say it, when it’s time to commercialize the Next Big Thing. Eight “idea champions” with entrepreneurial aspirations have completed Stony Brook University’s 2017 Innovation Boot Camp, a commercialization crash course that might not carry ideas directly to the promised land, but does give those inventors – mostly science…


CSHL spinoff earns $2M TopSpin buy-in

By GREGORY ZELLER // A cutting-edge Long Island biotech with a unique cancer-fighting platform has closed a critical $2 million funding round. DepYmed Inc., spun out of Cold Spring Harbor Laboratory with a little help from New York City stalwart Ohr Pharmaceutical, has announced the completion of a Series A funding round with TopSpin Fund LP, which is controlled by Roslyn-based VC and private-equity firm TopSpin Partners. The 2014 startup, which is developing multiple therapeutic…


Andrew Whiteley is now executively in residence

By GREGORY ZELLER // It’s become vogue for research institutions to staff “entrepreneurs-in-residence,” experienced innovators who can help science-based startups find their commercial footing, because they’ve been there and done that. Leave it to Cold Spring Harbor Laboratory to give the notion an innovative spin with a first-ever “executive-in-residence,” a 25-year life-sciences and drug-discovery veteran named Andrew Whiteley. In Whiteley, the lab doesn’t really have an entrepreneur – he’s never actually launched a new business himself – but it does…


DepYmed wins Accelerate funding

By Gregory Zeller // A Cold Spring Harbor biotech startup is the 10th and final recipient in the first co-funding round backed by Accelerate Long Island and the Long Island Emerging Technologies Fund. DepYmed, a joint venture of Cold Spring Harbor Laboratory and New York City-based biotech giant Ohr Pharmaceutical, will receive the 10th matching investment, with $50,000 coming from the regional business booster and $50,000 from the LIETF, a venture vehicle powered by Setauket…


DepYMed CEO Andreas Grill

Clinical trials for DepYMed

A joint venture between biotech stalwart Ohr Pharmaceutical and Cold Spring Harbor Laboratory is taking the fight to breast cancer – though a revolutionary treatment may still be a half-decade away at least. Cold Spring Harbor-based DepYMed, which incorporated just 10 months ago, is eyeing the first clinical trials of an enzyme inhibitor the company is proffering as a potential breakthrough for patients with HER2-positive breast cancer – a cancer that causes uncontrolled amplification in…